Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone increases muscle mass regardless of DHT conversion blocking.

Older men with low levels of a testosterone byproduct had a higher chance of developing an irregular heartbeat.

High serum DHT levels can help diagnose PCOS.

Sex hormones do not cause oral lichen planus.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

Spironolactone reduced hair thickness and some testosterone levels in women with excessive hair growth.

Men with androgenetic alopecia do not have elevated DHEA-S levels.

Men with hair loss don't necessarily have higher levels of the hormone DHEA-S, but this hormone tends to decrease with age.

A combination of nanomilled oral testosterone and dutasteride normalized testosterone levels in men with low testosterone and is safe for short-term use.

Finasteride significantly reduces DHT levels in male dogs without affecting testosterone levels, suggesting it could be used to treat benign prostatic hypertrophy in dogs weighing 10 to 50 kilograms.

Men with male pattern baldness don't necessarily have high levels of Dehydroepyandrosterone-sulfate, and there's no link between its levels and the severity of hair loss.

The herbal scalp serum may help hair growth by reducing DHT levels.

Cardiac risk markers help assess heart risk in males with type 2 diabetes and low DHT.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

Oral testosterone therapy raises heart risk more than other methods.

A new gene, JMJD1C, may affect testosterone levels in men.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Oophorectomy lowers testosterone and estrogen levels in both premenopausal and postmenopausal women, with postmenopausal women still producing significant testosterone.

MK-386 lowers DHT in blood and skin but not in semen.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

AMH is a promising biomarker for diagnosing PCOS.

Ozenoxacin reduces sebum production, helping manage acne.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Reduced androgens linked to kinky hair disorder and hair loss; 5a-reductase inhibitors may help.

Ursolic acid can shrink the prostate and lower a hormone linked to prostate growth in rats.

Androgenetic alopecia in males is linked to significant psychological distress, highlighting the need for both mental and dermatological care.

Hair mineral content can non-invasively monitor yak health and nutrition.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.